Results 2,501-2,520 of 9,393 for speaker:Alex White

Pensions and Retirement Lump Sums: Motion [Private Members] (6 Nov 2012)

Alex White: Not you.

Written Answers — Department of Health: Nursing Homes Support Scheme (6 Nov 2012)

Alex White: When the Nursing Homes Support Scheme commenced in October 2009, a commitment was made that it would be reviewed after three years. The reason for allowing this period to elapse is to ensure that trends and statistics will be available in order to inform the work. A public consultation process to inform the review concluded in mid-July. The issues raised by the Deputy in the details supplied...

Written Answers — Department of Health: Drug Treatment Programmes (6 Nov 2012)

Alex White: In line with the National Drugs Strategy, the Government is committed to continuing support for initiatives to tackle the drug problem, including programmes to help young parents overcome addiction. Coolmine Therapeutic Community (CTC) receives funding from my Department and the HSE to provide a range of services, including a specific residential programme targeting women, many of whom are...

Written Answers — Department of Health: General Practitioner Services (6 Nov 2012)

Alex White: Consultation fees charged by General Practitioners (GPs) to private patients, and to General Medical Services (GMS) patients outside the terms of the GMS contract, are a matter of private contract between the clinicians and the patients. While the Minister for Health has no role in relation to such fees, it is expected that clinicians would have regard to the overall economic situation in...

Written Answers — Department of Health: Medical Card Review (6 Nov 2012)

Alex White: Persons that are issued a medical card have a legal obligation under the Health Act 1970 to inform the HSE when they may no longer be entitled to hold a medical card. One requirement for the medical card is that the person is ordinarily resident in the State. Where a medical card is invalidated by the holder's circumstances, but the card holder has not informed the HSE, the State continues to...

Written Answers — Department of Health: Medical Card Applications (6 Nov 2012)

Alex White: As this is a service matter it has been referred to the Health Service Executive for direct reply to the Deputy.

Written Answers — Department of Health: Departmental Bodies (6 Nov 2012)

Alex White: The Health (Pricing and Supply of Medical Goods) Bill 2012 was published on the 13th of July 2012. The Bill completed its passage through the Seanad on Wednesday, the 19th of September, and is currently continuing its passage through the Dáil. An Implementation Group on Generic Substitution and Reference Pricing has been established and it held its inaugural meeting on the 9th of...

Written Answers — Department of Health: Medical Card Applications (6 Nov 2012)

Alex White: As this is a service matter it has been referred to the Health Service Executive for direct reply to the Deputy.

Written Answers — Department of Health: Medical Card Appeals (6 Nov 2012)

Alex White: As this is a service matter it has been referred to the Health Service Executive for direct reply to the Deputy.

Written Answers — Department of Health: Medical Card Applications (6 Nov 2012)

Alex White: As this is a service matter it has been referred to the Health Service Executive for direct reply to the Deputy.

Written Answers — Department of Health: Medical Card Eligibility (6 Nov 2012)

Alex White: As this is a service matter it has been referred to the Health Service Executive for direct reply to the Deputy.

Written Answers — Department of Health: Medicinal Products (6 Nov 2012)

Alex White: Under the Health (Pricing and Supply of Medical Goods) Bill, the Irish Medicines Board has statutory responsibility for establishing and publishing a list of interchangeable medicinal products in respect of which it is satisfied that all the medicinal products which fall into a group of interchangeable medicinal products are, for prescription purposes, interchangeable with each other. It is...

Written Answers — Department of Health: Medical Card Applications (6 Nov 2012)

Alex White: As this is a service matter it has been referred to the Health Service Executive for direct reply to the Deputy.

Written Answers — Department of Health: Health Service Expenditure (6 Nov 2012)

Alex White: I propose to take Questions Nos. 1024 to 1027, inclusive, together. The HSE estimates that expenditure in 2012 on drugs and non-drug items (dressings, etc.) under the GMS and community drug schemes, including mark ups and dispensing fees will be approximately €1.7 billion.In addition, about €300m will be spent on drugs and medicines used in public hospitals. The HSE estimates...

Written Answers — Department of Health: Medicinal Products (6 Nov 2012)

Alex White: The Health (Pricing and Supply of Medical Goods) Bill 2012 provides for the introduction of a system of generic substitution and reference pricing. Generic substitution allows pharmacists to substitute a cheaper generic equivalent, at the patient’s request, when a more expensive product has been prescribed. Reference pricing involves setting a common reimbursement amount for selected...

Written Answers — Department of Health: Medical Cards (6 Nov 2012)

Alex White: The Health (Pricing and Supply of Medical Goods) Bill 2012 provides for the introduction of a system of generic substitution and reference pricing. Generic substitution allows pharmacists to substitute a cheaper generic equivalent, at the patient’s request, when a more expensive product has been prescribed. Reference pricing involves setting a common reimbursement amount for selected...

Written Answers — Department of Health: Medical Card Appeals (6 Nov 2012)

Alex White: As this is a service matter it has been referred to the Health Service Executive for direct reply to the Deputy.

Written Answers — Department of Health: Drugs Payment Scheme (6 Nov 2012)

Alex White: The HSE recently received an application for Kalydeco's inclusion under the Community Drugs Scheme. In accordance with normal procedures, the National Centre for Pharmacoeconomics must conduct a Health Technology Assessment (HTA) on this product which will consider if the drug is cost effective at the price offered to the HSE. No reimbursement decision will be made until the HTA has been...

Written Answers — Department of Health: Medicinal Products (6 Nov 2012)

Alex White: My Department has been informed by the Irish Medicines Board (IMB) that it is in receipt of a market authorisation request from a manufacturer under the EU Mutual Recognition Procedure for a medicinal product containing Cannabis extract. This product is indicated for the relief of symptoms of spasticity for people with multiple sclerosis. Clinical trials in Ireland relating to this product...

Written Answers — Department of Health: Medical Cards (6 Nov 2012)

Alex White: I propose to take Questions Nos. 1040 and 1166 together. In the current financial environment the Health Service Executive (HSE) is facing a challenge to deliver services in a way that will minimise any adverse impact on patients and continue to protect, as far as possible, the most vulnerable citizens. Unfortunately, it has become necessary for the HSE to suspend certain products from its...